Orally administered betahistine and regional cerebral blood flow in cerebrovascular disease.
D000284:Administration, Oral; D000368:Aged; D006631:Amine Oxidase (Copper-Containing) / Q000037:antagonists & inhibitors*; D001621:Betahistine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000494:pharmacology*; D011868:Radioisotopes; D014978:Xenon
D011725:Pyridines; D011868:Radioisotopes; D014978:Xenon; D006631:Amine Oxidase (Copper-Containing); D001621:Betahistine